Researchers began to develop dual-site AChEIs that act on both CAS and PAS sites simultaneously, which can interfere with the aggregation of Aβ while enhancing the inhibitory activity of AChE, and play a dual role in the treatment of AD [30]. The gene discussed is ACHE; the disease is Alzheimer disease.